Today: 31 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks shares fell 2.5% to $84.91 on December 1 after agreeing to a $38.9 million New York City settlement over alleged violations of worker scheduling laws. The drop comes amid a nationwide union strike and split analyst views on the company’s outlook. Starbucks remains up 4.2% year-to-date but trades well below its 2021 peak.
2 December 2025
··
Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

A U.S. federal judge allowed a $6.7 billion lawsuit against Bristol-Myers Squibb over its 2019 Celgene acquisition to proceed, rejecting the company’s motion to dismiss key claims. BMY shares closed at $49.18 on December 1, up 7–8% over five days, but remain down for the year. The company’s annual dividend yield is about 5%. New cell therapy approvals and strong ASH 2025 hematology data also drew investor attention.
2 December 2025
·
Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont stock closed at $91.83 on December 1, 2025, more than doubling year-to-date after a 12% jump in November. UBS raised its price target to $125, citing strong gold prices and Newmont’s record free cash flow. The company posted Q3 net income of $1.8 billion and revenue of $5.52 billion, both beating estimates. Newmont has rapidly reduced debt and increased share buybacks.
2 December 2025
·
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health shares closed at $79.10 on December 1, 2025, down 1.6% and about 7% below their 52-week high. The stock is up nearly 79% year-to-date. Q3 revenue rose 7.8% to $102.9 billion, with adjusted EPS of $1.60 but a GAAP loss per share of –$3.13 due to a $5.7 billion non-cash goodwill impairment. CVS’s trailing P/E ratio spiked above 200 from the one-time charge.
2 December 2025
··
CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group halted trading for about 10 hours on November 28 after a cooling failure at a CyrusOne data center in Illinois, disrupting global futures and options markets. Shares closed at $279, down 0.9%, with a market cap over $100 billion. CME stock is up about 21% year-to-date, but some analysts warn it may be overvalued by up to 40%. The company paid $10.80 per share in dividends over the past year.
2 December 2025
·
Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin closed December 1, 2025, at about $856 per share, with a $109 billion market cap. The stock is up roughly 36% year-to-date, beating the S&P 500. Growth is driven by strong aerospace results and the $9.25 billion Filtration Group acquisition. Some models now estimate PH is overvalued by about 30%, though most analysts remain positive.
1 December 2025
·
KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

KKR shares closed near $122.50 on December 1, up from autumn lows but still 28% below the January peak of $170.40. The firm reported a strong Q3 earnings beat and faces new regulatory scrutiny as it joins the Bank of England’s private credit stress test. Market cap stands at about $108 billion. The next $0.19 dividend is set for December 2.
1 December 2025
··
HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

HCA Healthcare closed at about $503 on December 1, down 1% from Friday and just below its record high of $520 set in the prior session. Institutional investors shifted positions, with Dixon Mitchell raising its stake by 6.9% and others reducing holdings. The stock is up 71.5% year-to-date and trades at a discount to sector averages. Institutional holders control about 62.7% of shares.
1 December 2025
·
Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell (HON) Stock Today: Price, Earnings, Breakup Plan and 2026 Forecast (December 1, 2025)

Honeywell closed at $190.22 on December 1, down 1% for the day and about 16% below its 52-week high. The company recently beat Q3 earnings estimates, raised full-year guidance, and completed the Solstice Advanced Materials spin-off. Bank of America double-downgraded the stock to Underperform, while most analysts still rate it a Buy. Honeywell plans to split into Aerospace and Automation firms by 2026.
1 December 2025
···
Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo (WFC) Stock on December 1, 2025: Price, Dividend, Lawsuit Settlement and 2025–2030 Forecast

Wells Fargo shares closed at $85.4 on December 1, 2025, down just over half a percent, after hitting a record $88.54 in November. The bank reported Q3 net income of $5.6 billion, up from $5.1 billion a year earlier, and raised its medium-term ROTCE target to 17–18% after the Fed lifted its asset cap. Market cap stands near $270 billion. December 1 marked both a dividend payout and an $85 million class-action settlement.
1 December 2025
··
Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon Communications Inc. (VZ) Stock in December 2025: Earnings, 7% Dividend Yield and Frontier Deal Update

Verizon closed December 1, 2025, at $40–41 per share, with a $173 billion market cap and a 6.7–6.8% dividend yield. Third-quarter revenue reached $33.8 billion, up 1.5% year-over-year, while adjusted EPS was $1.21. Wireless service revenue rose to $21.0 billion. Total unsecured debt fell to $119.7 billion from $126.4 billion a year earlier.
1 December 2025
···
Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific (UNP) Stock on December 1, 2025: Merger Risks, Dividend Strength and Wall Street’s 2026 Price Targets

Union Pacific closed at $231.36 on December 1, 2025, valuing the company at $137 billion, with shares trading between $204.66 and $256.84 over the past year. Q3 adjusted EPS rose 12% to $3.08, net income climbed 9% to $1.8 billion, and operating revenue reached $6.24 billion. The company faces elevated regulatory and merger risk as it pursues an $85 billion Norfolk Southern deal.
1 December 2025
····
Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments (TXN) Stock on December 1, 2025: Earnings Hangover, $60 Billion Fab Bet and What Wall Street Expects Next

Texas Instruments shares traded near $168 on December 1, 2025, valuing the company at about $152 billion, down roughly 10% year-to-date and 16% over 12 months. Q3 revenue rose 14% to $4.74 billion, beating estimates, but the stock remains below its 52-week high as investors weigh heavy spending and a softer earnings outlook.
1 December 2025
··
Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron (CVX) Stock Today: HSBC Upgrade, CPC Drone Attack Fallout and 2030 Cash‑Flow Roadmap

Chevron shares traded at $152–153 on Monday after HSBC upgraded the stock to Buy and raised its price target to $169. The move follows a drone attack on a key export terminal and renewed focus on Chevron’s 2030 free-cash-flow plan. CVX yields 4.4–4.6% with a $1.71 quarterly dividend, and has returned 10.6% year to date. Market cap stands near $300 billion.
1 December 2025
··
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie shares closed near $225 on December 1, 2025, valuing the company at about $400 billion. Q3 net revenue rose 9.1% to $15.78 billion, with adjusted EPS of $1.86 topping estimates. The company raised its 2025 profit forecast and approved a 5.5% dividend increase. Immunology sales climbed, while Humira revenue dropped below $1 billion.
1 December 2025
····
Exxon Mobil (XOM) Stock Today: UBS Sets $145 Target as Guyana Output Surges and Dividend Yield Nears 3.5%

Exxon Mobil (XOM) Stock Today: UBS Sets $145 Target as Guyana Output Surges and Dividend Yield Nears 3.5%

Exxon Mobil traded near $117 on December 1, 2025, close to its 52-week high, with a market cap of about $492 billion. UBS issued a “Buy” rating and a $145 target, citing strong production in Guyana and the Permian. The company raised its quarterly dividend to $1.03 per share, yielding 3.5%. Oil prices remain subdued, with Brent at $63 and OPEC+ maintaining current output cuts.
1 December 2025
···
Analog Devices (ADI) Stock on December 1, 2025: Earnings Momentum, Insider Moves and 2026 Forecasts

Analog Devices (ADI) Stock on December 1, 2025: Earnings Momentum, Insider Moves and 2026 Forecasts

Analog Devices closed December 1, 2025 at $266.51, near record highs after a post-earnings surge and analyst upgrades. Q4 revenue rose 26% to $3.08 billion, beating forecasts, with adjusted EPS up 35% to $2.26. Several valuation models now flag the stock as expensive, and technical signals show overbought conditions. Shares are up 26% year-to-date but have trailed the broader tech sector’s gains.
1 December 2025
··
1 … 827 828 829 830 831 … 863

Stock Market Today

  • Nanobiotix Raises €85 Million to Advance JNJ-1900 Cancer Treatment Amid Volatile Stock Rally
    May 30, 2026, 6:54 PM EDT. Nanobiotix (ENXTPA:NANO) completed a €85 million global equity raise to fund the development of JNJ-1900 (NBTXR3), a leading cancer treatment candidate. The financing follows promising Phase 2 trial results in inoperable non-small cell lung cancer, sponsored by Johnson & Johnson. Despite a recent 6.6% dip, shares have soared over 79% year-to-date, closing at €34.04, reflecting high market sensitivity to company developments. The fundraise attracted both European and U.S. investors through ordinary shares, American Depositary Shares, and pre-funded warrants issued near the current share price, suggesting robust demand without steep discounting. Investors will closely monitor Nanobiotix's clinical progress, regulatory updates, and potential partnerships, amid dilution concerns due to the new equity issue.

Latest articles

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

31 May 2026
Realty Income closed Friday at $61.28, down from $62.02 the previous week, as property stocks lagged broader market gains. The company declared a $0.2705 monthly dividend, payable June 15 to shareholders of record May 29. CEO Sumit Roy will present at Nareit’s REITweek on June 3. Investors await the U.S. May jobs report on June 5.
Oklo Stock Higher After Plutonium-Fuel Update

Oklo Stock Higher After Plutonium-Fuel Update

31 May 2026
Oklo shares closed at $66.88 Friday, down 1.78%, after a week of gains sparked by news the U.S. Department of Energy selected the company for advanced talks on using surplus plutonium as reactor fuel. Trading volume reached 27.67 million shares. Oklo reported a first-quarter net loss of $33.1 million and ended March with $2.54 billion in cash and equivalents.
Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

31 May 2026
Cameco shares closed Friday at C$154.91 on the TSX, up 7.1% for the week after full production resumed at McArthur River and Key Lake following flood-related disruptions. The company kept its 2026 uranium output guidance unchanged at 19.5–21.5 million pounds. CIBC and National Bank of Canada maintained “Outperform” ratings. Cameco reported Q1 net earnings of C$131 million earlier in May.
Go toTop